Show results for
Refine by
Genomics Expands Its Sequencing Equipment Supplied In Europe
11 equipment items found
Manufactured by:Agilent Technologies, Inc. based inSanta Clara, CALIFORNIA (USA)
The SureSelect Target Enrichment System is the most proven target enrichment solution today. This technology enables the capture of genomic targets using long 120nt RNA baits which allow for efficient enrichment of regions of interest facilitating confident variant calling. The SureSelectQXT Reagent Kit is a combined shearing-free transposase-based library prep and target enrichment solution that ...
by:Eligo Bioscience based inParis, FRANCE
Eligobiotics are a first-in-class proprietary modality that enables the delivery and expression of therapeutic DNA in target bacterial populations of the microbiome. This technology allows modulation of the microbiome’s composition and function to address human disease with an unprecedented ...
Manufactured by:Metabogen AB based inStockholm, SWEDEN
Over the past decade, the scientific discoveries related to the human microbiome and how it influences health, has made the industry consider novel approaches. New needs to understand how changes in the microbiome may contribute to disease or treatment outcome are created. ...
by:Procarta Biosystems Ltd based inNorwich, UNITED KINGDOM
Proprietary nanoparticles deliver an oligonucleotide inside the bacterial pathogen. The oligonucleotide acts as a Transcription Factor Decoy (TFD): it contains the binding site of a transcription factor that controls a large set of genes required for the survival of the bacterium. The TFD acts as a competitive inhibitor to prevent these genes being turned on and so prevents growth and treats the ...
Manufactured by:Lexogen GmbH based inVienna, AUSTRIA
Biases in RNA Sequencing: RNA sequencing (RNA-Seq) workflows comprise RNA purification, library generation, the sequencing itself, and the evaluation of the sequenced fragments. The initial steps impose biases for which the data processing algorithms try to compensate afterwards. Key tasks for data evaluation algorithms are the concordant assignment of fragments to the transcript variants, ...
Manufactured by:Thermo Fisher Scientific based inWaltham, MASSACHUSETTS (USA)
Choose from a menu of verified real-time PCR assays to build your own custom Applied Biosystems TaqMan SARS-CoV-2 Mutation Panel, and get the results you need today, while preparing you for what’s to come. This scalable solution lets you run a few or hundreds of samples to identify one or many mutations—all on your current real-time PCR ...
by:STALICLA based inGeneve, SWITZERLAND
STALICLA’s precision medicine approach begins with ‘endophenotyping’-identifying the nonbehavioral physical and molecular presentations of NDDs and characterizing subgroups of patients with similar disease signatures. DEPI matches these patient subgroups with an NDD-targeted drug (or drug combination) by integrating and analyzing large omics data sets, including genomics, ...
by:Evaxion Biotech A/S based inHørsholm, DENMARK
EDEN is our second AI platform that rapidly identifies novel, highly protective antigens for the use in pathogen-specific prophylactic vaccines against bacteria. EDEN has been designed to rapidly identify those antigens that will trigger a robust protective immune response against almost any bacterial infectious disease. In addition, EDEN redesigns identified antigens to optimize their antigenic ...
by:GenomSys based inPréverenges, SWITZERLAND
GenomSys Variant Analyzer is a CE-marked platform natively operating on MPEG-G genomic data format that enables accurate variants identification, annotation, and interpretation (SNVs, indels, CNVs). Based on state-of-the-art pipelines and leveraging MPEG-G-specific features, GenomSys Variant Analyzer supports professionals in the diagnostic process and selecting treatment options. Our Variant ...
Manufactured by:Kiadis Pharma NV based inAmsterdam, NETHERLANDS
We believe our IntelliSelect® Technology platforms reduce the risk of missing novel solutions and increase the quality and differentiation of antibodies, to identify product candidates with the most desirable drug-like ...
Manufactured by:Population Bio, Inc. a Precision Medicine Company based inMelville, NEW YORK (USA)
Population Bio’s patented CNV Beacon® platform is a rapid genetic discovery method that focuses first on identifying disease-relevant copy number variants (CNVs). Once a gene or genomic region is discovered via a CNV, other types of genetic variants – such as single nucleotide variants (SNVs) – can be efficiently revealed to determine the full spectrum of variants that cause ...